Press release
cerboMed appoints Christoph A. Bally as Chief Executive Officer
Christoph Bally
cerboMed GmbH from Erlangen, Germany, announces today that Christoph Bally has been appointed as the company’s Chief Executive Officer in order to further strengthen the existing management team of the two company founders, Stefan Dietrich and Timo Freitag.
Christoph Bally will be able to contribute to the company’s future development and success based on his experience from the Life Science industry. During his career spanning over close to 20 years, the 44-years old Swiss citizen has been able to collect experiences in Diagnostics, Pharma and Medical Devices with different companies including Serono, Schering-Plough, Disetronic and Roche. Prior to being the co-founder and CEO of a Nutri-Technology company in Zurich, Switzerland, in 2003, Mr. Bally held a Vice-President position with Roche overseeing Global Program Management and Strategic Planning of Roche’s insulin pump division acquired from Disetronic Medical Systems. He had spent 6 years with Disetronic contributing to its growth in various Senior Management positions in Global Marketing, Business Development and as the General Manager in France.
“We are looking forward to working together with Christoph as our new CEO and bringing the required Life Sciences expertise to cerboMed“ says Timo Freitag, Chief Marketing Officer. „Christoph will be able to further strengthen our focus and achieve our ambitious objectives“ adds Stefan Dietrich, Chief Scientific Officer.
The investors behind cerboMed, MIG AG, S‐Refit AG, medTECH Capital Fonds GmbH and KfW had coached the selection of Mr. Bally and Michael Motschmann, CEO of MIG AG, commenting on this appointment said: „With Christoph we have found a dynamic Senior Manager and Entrepreneur with an international track record whose experiences and skills are ideally suited to prepare cerboMed for the future.“
Christoph Bally holds a degree in economics and an MBA and has been dealing with various medical disciplines during his past career. Beside Marketing, General Management and Strategic Planning, he also had the opportunity to manage interdisciplinary teams in technology-oriented companies. Mr. Bally is married and father of two children.
„cerboMed’s innovation has a great potential for people with neuropsychiatric disorders“ says Bally. „With the professional support of our investors we will increase pace and ambition of our strategy and look forward to a series of clinical results initiated during 2009. We have an exciting technology, excellent and acknowledged cooperation clinical and scientific partners as well as a highly motivated and specialized team.“
About cerboMed: cerboMed is a young, medical device company focusing on the research, development and manufacturing of technologies and products in the area of neurostimulation. Its major proprietary procedure, transcutaneous Vagus Nerve Stimulation (t-VNS®), will offer a new, alternative treatment for various neurophysiological disorders with clinical benefit and improved quality of life at a lower cost.
Founded in 2005, cerboMed has received several innovation and entrepreneur awards including Hochschul-Gruenderpreis, and IHK-Gruenderpreis – and was among the national winners of the Ger¬man Entrepreneur Award (Deutscher Gruenderpreis) in 2006. cerboMed has closed its fourth financing round in 2008 with various venture capital partners.
cerboMed GmbH
Mrs. Simone Duve
Head of Corporate Communication
Henkestr. 91
DE - 91052 Erlangen
Fon: +49 (0)9131 92 02 76 30
simone.duve@cerboMed.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release cerboMed appoints Christoph A. Bally as Chief Executive Officer here
News-ID: 82443 • Views: …
More Releases from cerboMed GmbH
Pharmaceuticals and medical technology will go hand in hand in future – DESITI …
ERLANGEN/HAMBURG, September 17th, 2015 – The medical technology company cerbomed GmbH from Erlangen and the pharmaceutical company DESITIN Arzneimittel GmbH from Hamburg have entered into a groundbreaking distribution agreement: DESITIN has been granted exclusive distribution rights in Germany by cerbomed for the transcutaneous vagus nerve stimulator NEMOS for treatment of epilepsy.
The successful medium-sized independent company DESITIN has been a specialist provider and proficient partner to doctors and patients in the…
transcutaneous Vagus Nerve Stimulation for epilepsies now available in Norway
ERLANGEN/DRAMMEN, May 28th, 2015 – To address the Norwegian market with transcutaneous Vagus Nerve Stimulation (t-VNS), the medical device company cerbomed from Erlangen, Germany, is cooperating with an experienced distribution partner: Scan-Med A/S from Drammen, Norway.
The company, founded in 1982, considers itself as a connecting link between manufacturers of medical devices and hospitals, as well as health institutions and specialized on distribution service and support of medical equipment.
“We are…
Vagus nerve stimulation without surgery now available in Denmark, Finland and Sw …
ERLANGEN/AALBORG, Mai 28th, 2015 – More than 30 percent of all epilepsy patients still suffer from continued occurrence of seizures, despite appropriate treatment with anticonvulsive drugs. For these patients, only few treatment alternatives are available at the moment. One promising therapy option is transcutaneous Vagus Nerve Stimulation (t-VNS), now also available for patients in Denmark, Sweden and Finland. This has been made possible by cerbomed‘s new distributor Cephalon A/S.…
Trial results for transcutaneous Vagus Nerve Stimulation in pharmacoresistant ep …
ERLANGEN/DRESDEN, 30th April 2015 – At the 9th annual joint conference of the three German-speaking regions of the International League Against Epilepsy in Dresden, the results of a trial on transcutaneous Vagus Nerve Stimulation (t-VNS) in pharmacoresistant epilepsy were presented for the first time.
Trial shows reduction in seizures with t-VNS
In the multi-centre, randomised, controlled, 2-arm, double-blind study, 76 adult epilepsy patients from Germany and Austria were treated over 5…
More Releases for Bally
Leather Wallet Market Classic Elegance and Practicality 2023 to 2030 | BURBERRY, …
The Leather Wallet Market is experiencing steady growth and presenting lucrative opportunities for both established players and new entrants. The increasing demand for stylish and durable accessories, coupled with a growing preference for luxury items, has been driving the expansion of the leather wallet industry. As consumers become more fashion-conscious and seek products that reflect their personal style, the market has responded with a diverse range of designs, sizes, and…
Leather Wallet Market Is Booming Worldwide | Bally, Gucci, Fossil, Saddleback Le …
A Latest intelligence report published by AMA Research with title "Global Leather Wallet Market Outlook to 2028. A detailed study accumulated to offer Latest insights about acute features of the Leather Wallet market. This report provides a detailed overview of key factors in the Global Leather Wallet Market and factors such as driver, restraint, past and current trends, regulatory scenarios and technology development.
Definition: The leather wallet is made of…
Static Control Fabric market: Players tapping Emerging Markets | Marian, Bally R …
"The global Static Control Fabric Market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Static Control Fabric Market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of…
Flexible Composites market: Market Players Leveraging on Growth Opportunities | …
"
The Flexible Composites global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key factors.…
Leather Wallet Market Will Generate Massive Revenue in Coming Years | BURBERRY, …
The Leather Wallet Market has witnessed continuous growth in past few years and is projected to grow at good pace during the forecast period of 2022-2028. The exploration provides a 360° view and insights, highlighting major outcomes of Leather Wallet industry. These insights help the business decision-makers to formulate better business plans and make informed decisions to improved profitability. Additionally, the study helps venture or emerging players in understanding the…
Leather Wallet Market Is Booming Worldwide | Gucci, Bally, HUGO BOSS
Latest Report Available at Advance Market Analytics, “Leather Wallet Market” provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
The global Leather Wallet market focuses on encompassing major statistical evidence for the Leather Wallet industry as it offers our readers a value addition on guiding them in encountering the obstacles surrounding the market. A comprehensive addition of several factors such…
